Company news
Phathom Pharmaceuticals, Inc. news in 2019
Phathom Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Phathom Pharmaceuticals Announces Initiation of Pivotal Phase 3 Clinical Trial for Vonoprazan in Helicobacter Pylori (H. pylori) Infection
December 22, 2019
Phathom Pharmaceuticals Expands Leadership Team and Announces Board Transition
December 1, 2019
Phathom Pharmaceuticals Announces Initiation of Pivotal Phase 3 Clinical Trial for Vonoprazan in Erosive Esophagitis
December 1, 2019
Phathom Pharmaceuticals to Present at Evercore ISI 2019 HealthCONx Conference
November 25, 2019
Phathom Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 24, 2019
Phathom Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 28, 2019